US Stem Cell Inc (USRM)

[Dragon Lady]

3.3 MILLION on Bid @ .0012 HOLY COW !!

0.0012 / 0.0013 (3390000 x 10000)

Uh oh, possibly back to the new all, all, all TIME LOW of .0013 or EVEN LOWER to a new all, all, all TIME LOW OF .0012 now????

Market cap on several finance sites now shows as $1.28 MILLION lousy bucks, holy cow. What if it breaks a market cap of $1 million pittance dollars? Just their accounts payable, aka most immediate debts, on their most recent SEC filed 10-Q were like over $2 MILLION dollars, now almost twice their market cap? WOWZA, holy freaking cow that's a stunner !

The only thing that's gonna prop that massively collapsing market cap back up, looks like to me, is when they get the new massive increased dilution share numbers published in their next 10-Q, LOL !! Imagine that- it takes dilution shares being added to prop the market cap calculation back up as it's literally sagging to near ZERO in real time. That ain't good- no way, no how in my book?

.0013 on the Ask again and a new ALL TIME LOW BID of .0012 now, HOLY COW. Dropping like a lead brick going to the bottom. Wowza !!

If the dilution MM's take it on a big ole next leg DOWN from here- then it's gonna hit the .001 range or even sub .001 next IMO. It's incredibly weak looking here IMO. Just in total free-fall of the Bid/Ask that I can see? Even when the MM's have jacked the Ask up a tad, the Bid has never really moved off the ultra new lows. It's a train wreck looks like to me and just getting worse, the lower it goes. Which is "normal" in the death spiral scenario as described at the SEC site, Bloomberg, Wiki and numerous other places that explain it and the negative, destructive effects of endless use of toxic convertible debt.

Last Friday they just inked another toxic note with ole Magna. Magna from everything I've found and read on the internet and right here at I-HUB, is a notorious PRICE CRUSHER. NOT looking good here IMO.

http://www.bloomberg.com/news/articles/2015-03-12/josh-sason-made-millions-from-penny-stock-financing

http://investorshub.advfn.com/Clients-of-Magna-Group-and-Hanover-Holdings-25550/

And that's just Magna. BHRT also uses/used notorious Asher of Curt Kramer fame as a penny hedge lender of last resort for multiple cash-for-convertible-shares "notes", aka "toxic notes" typically- and now believed to run KBM Worldwide and also Vis Vires group- who BHRT has also done recent "toxic", aka steeply discounted and "floorless" "notes" as the SEC site describes this type of "note" financing deals. WOWZA !

http://investorshub.advfn.com/~-ASHER-~-25451/

http://www.hollywoodreporter.com/news/afm-daniel-grodnik-teams-kramer-747466

http://www.bloomberg.com/research/stocks/private/person.asp?personId=286760008&privcapId=286590246&previousCapId=286590246&previousTitle=Vis%20Vires%20Group,%20Inc.

http://www.streetinsider.com/SEC+Filings/Form+SC+13G+Trio+Resources,+Inc.+Filed+by%3A+VIS+VIRES+GROUP,+INC./10681995.html

Notice, that SEC form for "VIS VIRES" group was signed by "Curt Kramer" as "President". It appears to be one in the same as ole Asher "fame" and now also KBM Worldwide, run by his brother "Seth" according to numerous web sites easily found via a Google search.

Last BHRT SEC filed 10-Q, PAGE 15/16:

"Asher Notes (During this period)

During the six months ended June 30, 2015, the Company entered into Securities Purchase Agreements with Asher Enterprises, Inc. (“Asher”) or affiliates, for the sale of 8% convertible notes in aggregate principal amount of $180,000 (the “Asher Notes”). The Company incurred legal fees in the amount of $15,000 which were deducted from the proceeds of the notes.

The Asher Notes bear interest at the rate of 8% per annum. As of the six months ended June 30, 2015, all interest and principal must be repaid nine months from the issuance date, with the last note being due February 6, 2016. The Asher Notes are convertible into shares of common stock, at Asher’s option, at a 45% discount to the average of the three lowest closing bid prices of the shares of common stock during the 10 trading day period prior to conversion. The Company has identified the embedded derivatives related to the Asher Notes.

These embedded derivatives included certain conversion features and reset provision. The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date of Asher Notes and to fair value as of each subsequent reporting date, which at June 30, 2015 was $307,285. At the inception of the Asher Notes, the Company determined the aggregate fair value of $211,575 of the embedded derivatives.

During the six months ended June 30, 2015, $151,000 of notes that were outstanding at December 31, 2014, plus accrued interest, were converted into shares of the Company’s common stock (see Note 10).

The remaining aggregate Asher Notes unconverted principle balance as of June 30, 2015 was $180,000.

Daniel James Management (During this period)

During the six months ended June 30, 2015, the Company entered into Securities Purchase Agreements with Daniel James Management (“Daniel”) for the sale of 9.5% convertible note in aggregate principal amount of $75,000 (the “Daniel Note”).

The Daniel Notes bear interest at the rate of 9.5% per annum. As of the six months ended June 30, 2015, all interest and principal must be repaid one year from the issuance date, with the last note being due June 28, 2016. The Daniel Notes are convertible into common stock, at holder’s option, at a 47% discount to the average of the three lowest closing bid prices of the common stock during the 10 trading day period prior to conversion. The Company has identified the embedded derivatives related to the Daniel Notes. These embedded derivatives included certain conversion features and reset provision.

The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date of Daniel Notes and to fair value as of each subsequent reporting date which at June 30, 2015 was $151,894. At the inception of the Daniel Notes, the Company determined the aggregate fair value of $137,578 of the embedded derivatives.

During the six months ended June 30, 2015, $75,000 of notes that were outstanding at December 31, 2014, plus accrued interest were converted into shares of the Company’s common stock (see Note 10).

The remaining aggregate Daniel Notes unconverted principle balance as of June 30, 2015 was $75,000.

Fourth Man, LLC (During this period)

During the six months ended June 30, 2015, the Company entered into Securities Purchase Agreements with Fourth Man, LLC. (“Fourth Man”), for the sale of a 9.5% convertible notes in the aggregate principal amount of $75,000 (the “Note”).

The Notes bears interest at the rate of 8% to 9.5% per annum. As of the six months ended June 30, 2015, all interest and principal must be repaid one year from the issuance date, with the last note being due May 31, 2016. The Notes are convertible into shares of common stock, at Fourth Man’s option, at a 47% discount to the lowest closing bid price of the common stock during the 10 trading day period prior to conversion. The Company has identified the embedded derivatives related to the Fourth Man Notes. These embedded derivatives included certain conversion features and reset provision.

The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date of Fourth Man Notes and to fair value as of each subsequent reporting date which at June 30, 2015 was $150,554. At the inception of the Fourth Man Notes, the Company determined the aggregate fair value of $143,097 of the embedded derivatives.

During the six months ended June 30, 2015, $75,000 of notes that were outstanding at December 31, 2014, plus accrued interest, were converted into shares of the Company’s common stock (see Note 10).

The remaining aggregate Fourth Man, LLC Notes unconverted principle balance as of June 30, 2015 was $75,000.

Magna Group (During this period)

During the six months ended June 30, 2015, $75,000 of notes that were outstanding at December 31, 2014, plus accrued interest, were converted into shares of the Company’s common stock (see Note 10). The remaining aggregate Magna notes unconverted principle balance as of June 30, 2015 was $130,000."

BHRT last filed SEC 10-K, PAGE F-34:

"Subsequent financing

On January 7, 2015, the Company entered into a Securities Purchase Agreement with KBM Worldwide, Inc. (“KBM”), for the sale of an 8% convertible note in the principal amount of $38,000 (the “Note”).

The Note bears interest at the rate of 8% per annum. All interest and principal must be repaid on October 9, 2015. The Note is convertible into common stock, at KBM’s option, at a 45% discount to the average of the three lowest closing bid prices of the common stock during the 10 trading day period prior to conversion. In the event the Company prepays the Note in full, the Company is required to pay off all principal, interest and any other amounts owing multiplied by (i) 140% if prepaid during the period commencing on the closing date through 179 days thereafter. After the expiration of 180 days following the date of the Note, the Company has no right of prepayment.

On January 28, 2015, the Company entered into a Securities Purchase Agreement with Fourth Man, LLC., for the sale of an 9.5% convertible note in the principal amount of $25,000 (the “Note”).

The Note bears interest at the rate of 9.5% per annum. All interest and principal must be repaid on January 27, 2016. The Note is convertible into common stock, at Asher’s option, at a 47% discount to the lowest daily closing trading price of the common stock during the 10 trading day period prior to conversion. In the event the Company prepays the Note in full, the Company is required to pay off all principal at 150%, interest and any other amounts.

On February 19, 2015, the Company entered into a Securities Purchase Agreement with Vis Vires Group, Inc. (“VIS”), for the sale of an 8% convertible note in the principal amount of $38,000 (the “Note”).

The Note bears interest at the rate of 8% per annum. All interest and principal must be repaid on November 23, 2015. The Note is convertible into common stock, at VIS’s option, at a 45% discount to the average of the three lowest closing bid prices of the common stock during the 10 trading day period prior to conversion. In the event the Company prepays the Note in full, the Company is required to pay off all principal, interest and any other amounts owing multiplied by (i) 140% if prepaid during the period commencing on the closing date through 179 days thereafter. After the expiration of 180 days following the date of the Note, the Company has no right of prepayment.
"

HOLY COW, "note" borrowed after "note" after "note" just un-ending looks like to me? ALL that dilution has got to have some effect (negative) in the end seems to me- JUST like what is happening to the common shares now, and essentially for pretty much all of 2015 IMO.

My .0012 or so Bid CENTS WORTH, for whatever that's worth, which ain't much, LOL !! Looks like this sinking ship is taking on water fast and heading for the bottom. It's hurricane season after all- and they seem to be in the eye of the perfect storm to me.